Weekly Recap | Editas Medicine -16.41%, consensus target above spotWeekly Review·18 minutes agoEDIT+1.89%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·39 minutes agoCAI+1.25%
Weekly Recap | Sellas Life Sciences -16.7%, Friday's heavy-volume slideWeekly Review·1 hour agoSLS-14.42%
Weekly Recap | Revolution Medicines -2.98%, consensus target above spotWeekly Review·1 hour agoRVMD+0.21%
Weekly Recap | Regeneron Pharma -5.59%, class action deadline passesWeekly Review·1 hour agoREGN-1.48%
Weekly Recap | Larimar Therapeutics +2.35%, most brokers rate it buyWeekly Review·2 hours agoLRMR+1.82%
Weekly Recap | SPDR S&P Biotech -4.65%, most brokers rate it buyWeekly Review·3 hours agoXBI-0.40%LABD+1.23%
